First Author | Matsumura K | Year | 2016 |
Journal | J Immunol | Volume | 197 |
Issue | 8 | Pages | 3233-3244 |
PubMed ID | 27605010 | Mgi Jnum | J:294805 |
Mgi Id | MGI:6458615 | Doi | 10.4049/jimmunol.1601010 |
Citation | Matsumura K, et al. (2016) Peroxiredoxin 1 Contributes to Host Defenses against Mycobacterium tuberculosis. J Immunol 197(8):3233-3244 |
abstractText | Peroxiredoxin (PRDX)1 is an antioxidant that detoxifies hydrogen peroxide and peroxinitrite. Compared with wild-type (WT) mice, Prdx1-deficient (Prdx1(-/-)) mice showed increased susceptibility to Mycobacterium tuberculosis and lower levels of IFN-gamma and IFN-gamma-producing CD4(+) T cells in the lungs after M. tuberculosis infection. IL-12 production, c-Rel induction, and p38 MAPK activation levels were lower in Prdx1(-/-) than in WT bone marrow-derived macrophages (BMDMs). IFN-gamma-activated Prdx1(-/-) BMDMs did not kill M. tubercuosis effectively. NO production levels were lower, and arginase activity and arginase 1 (Arg1) expression levels were higher, in IFN-gamma-activated Prdx1(-/-) than in WT BMDMs after M. tuberculosis infection. An arginase inhibitor, N(omega)-hydroxy-nor-arginine, restored antimicrobial activity and NO production in IFN-gamma-activated Prdx1(-/-) BMDMs after M. tuberculosis infection. These results suggest that PRDX1 contributes to host defenses against M. tuberculosis PRDX1 positively regulates IL-12 production by inducing c-Rel and activating p38 MAPK, and it positively regulates NO production by suppressing Arg1 expression in macrophages infected with M. tuberculosis. |